Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Compugen (CGEN)

Compugen Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CGEN
DateTimeSourceHeadlineSymbolCompany
01/04/201111:13Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
21/03/201113:22Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CGENCompugen Ltd
07/03/201112:01Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
07/03/201112:00Business WireCompugen Announces Positive Animal Model Results for Novel Peptide Predicted to Block Protein-Protein InteractionNASDAQ:CGENCompugen Ltd
15/02/201112:02Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
15/02/201112:00Business WireCompugen Ltd. Reports Fourth Quarter and Calendar 2010 Financial ResultsNASDAQ:CGENCompugen Ltd
14/02/201119:38Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CGENCompugen Ltd
11/02/201118:04Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CGENCompugen Ltd
08/02/201112:00Business WireCompugen Ltd. to Review Fourth Quarter and Year-End 2010 Financial Results on Tuesday, February 15, 2011NASDAQ:CGENCompugen Ltd
25/01/201118:15Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:CGENCompugen Ltd
11/01/201121:37Edgar (US Regulatory)Securities Registration (foreign private issuer) (F-3)NASDAQ:CGENCompugen Ltd
30/12/201012:01Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
30/12/201012:00Business WireCompugen Signs $5 Million R&D Funding Agreement in Support of its Pipeline ProgramNASDAQ:CGENCompugen Ltd
14/12/201012:01Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
14/12/201012:00Business WireCompugen Announces Positive Therapeutic Effect of CGEN-15001 in Animal Model of Rheumatoid ArthritisNASDAQ:CGENCompugen Ltd
06/12/201012:01Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
06/12/201012:00Business WireNew Studies Support Therapeutic Potential of Compugen Discovered Target for Multiple Myeloma TreatmentNASDAQ:CGENCompugen Ltd
22/11/201012:05Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
22/11/201012:00Business WireCompugen Announces Discovery Platform for New Members of Protein Families with Known Therapeutic ApplicationsNASDAQ:CGENCompugen Ltd
29/10/201012:00Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
29/10/201012:00Business WireCompugen Licenses Novel Oncology Target to Seattle GeneticsNASDAQ:CGENCompugen Ltd
26/10/201012:05Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
26/10/201012:00Business WireCompugen Reports Third Quarter 2010 Financial ResultsNASDAQ:CGENCompugen Ltd
19/10/201012:00Business WireCompugen Ltd. to Review Third Quarter 2010 Financial Results on Tuesday, October 26, 2010NASDAQ:CGENCompugen Ltd
21/09/201013:10Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
07/09/201017:44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:CGENCompugen Ltd
27/07/201012:06Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
27/07/201012:00Business WireCompugen Reports Second Quarter 2010 Financial ResultsNASDAQ:CGENCompugen Ltd
20/07/201012:00Business WireCompugen Second Quarter 2010 Webcast and Conference Call Scheduled for Tuesday, July 27, 2010 at 10:00 AM EDTNASDAQ:CGENCompugen Ltd
01/07/201012:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
 Showing the most relevant articles for your search:NASDAQ:CGEN

Your Recent History

Delayed Upgrade Clock